30LBA A Phase 1 dose escalation, safety, and pharmacokinetic study of PF-06650808, an anti-Notch3 antibody drug conjugate, in adult patients with advanced solid tumors

Autor:	J. Masters, S.Y. Hua, Anthony W. Tolcher, R. Shazer, K.H. Liao, S. Deng, Lee S. Rosen, R. Wesolowski, Brenda Gibson, R. Baffa
Rok vydání:	2015
Předmět:	Cancer Research Antibody-drug conjugate Oncology Adult patients Pharmacokinetics business.industry Dose escalation Medicine Pharmacology business
Zdroj:	European Journal of Cancer. 51:S725
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(16)31948-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::34754ec02740ae4f5b500cd3ef78f1ca https://doi.org/10.1016/s0959-8049(16)31948-7 Zobrazit plný text záznamu Full Text from ScienceDirect